Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Simpson, E.L., Bieber, T., Guttman-Yassky, E. et al. (23 more authors) (2016) Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. The New England Journal of Medicine. ISSN 0028-4793

Abstract

Metadata

Authors/Creators:
  • Simpson, E.L.
  • Bieber, T.
  • Guttman-Yassky, E.
  • Beck, L.A.
  • Blauvelt, A.
  • Cork, M.J.
  • Silverberg, J.I.
  • Deleuran, M.
  • Kataoka, Y.
  • Lacour, J.P.
  • Kingo, K.
  • Worm, M.
  • Poulin, Y.
  • Wollenberg, A.
  • Soo, Y.
  • Graham, N.M.
  • Pirozzi, G.
  • Akinlade, B.
  • Staudinger, H.
  • Mastey, V.
  • Eckert, L.
  • Gadkari, A.
  • Stahl, N.
  • Yancopoulos, G.D.
  • Ardeleanu, M.
  • SOLO 1 and SOLO 2 Investigators,
Copyright, Publisher and Additional Information: © 2016 Massachusetts Medical Society. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 1 October 2016
  • Published: 1 October 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Cardiovascular Science (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 05 Oct 2016 13:49
Last Modified: 22 Mar 2018 16:22
Published Version: http://dx.doi.org/10.1056/NEJMoa1610020
Status: Published
Publisher: Massachusetts Medical Society
Refereed: Yes
Identification Number: https://doi.org/10.1056/NEJMoa1610020

Share / Export

Statistics